- Home
- RVTY
RVTY
Revvity Inc.
as 11-20-2024 4:00pm EST
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
| Founded: | 1937 | Country: | United States |
| Employees: | N/A | City: | WALTHAM |
| Market Cap: | 15.1B | IPO Year: | N/A |
| Target Price: | $129.40 | AVG Volume (30 days): | 1.0M |
| Analyst Decision: | Buy | Number of Analysts: | 16 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 2.06 | EPS Growth: | -65.18 |
| 52 Week Low/High: | $86.30 - $129.50 | Next Earning Date: | 11-04-2024 |
| Revenue: | $2,721,555,000 | Revenue Growth: | -2.66% |
| Revenue Growth (this year): | 2.34% | Revenue Growth (next year): | 5.58% |
Stock Insider Trading Activity of Revvity Inc. (RVTY)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Vohra Tajinder S | RVTY | Please See Remarks | Oct 9 '24 | Sell | $122.14 | 2,154 | $262,201.68 | 19,672 |
Latest Revvity Inc. News
RVTY Breaking Stock News: Dive into RVTY Ticker-Specific Updates for Smart Investing
Business Wire
21 hours ago
Revvity Broadens Relationship with Genomics England to Advance Genomics in the UK
Business Wire
2 days ago
Scale Biosciences and Revvity’s BioLegend Launch First-of-its-Kind Solution for High Parameter Protein Profiling of Single Cells
Business Wire
2 days ago
Revvity to Present at 7th Annual Evercore ISI HealthCONx Conference
Business Wire
3 days ago
Revvity to Host Investor Day and Updates Organizational Structure to Reflect Recent Transformation
Simply Wall St.
8 days ago
We Think Revvity's (NYSE:RVTY) Healthy Earnings Might Be Conservative
Argus Research
8 days ago
RVTY: Lowering target price to $126.00
Argus Research
15 days ago
RVTY: Raising target price to $132.00
MT Newswires
16 days ago
UBS Raises Revvity Price Target to $145 From $140, Maintains Neutral Rating
Compare RVTY vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RVTY Revvity Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.